Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aker BioMarine ASA ( (DE:1PG) ) has issued an announcement.
Aker BioMarine will publish its fourth-quarter 2025 results on 12 February 2026 at 07:00 CET, followed by a management webcast presentation and written Q&A session at 09:00 CET, with live access and replay available via the company’s investor relations website. The scheduled results release and webcast underline the company’s ongoing engagement with investors and analysts, offering transparency around financial performance and strategic progress in its krill-based nutrition and related businesses.
More about Aker BioMarine ASA
Aker BioMarine is a human health and nutrition company that develops krill-derived products sourced from Antarctic waters, positioning itself as a leading innovator in marine-based ingredients. Its portfolio includes Superba Krill Oil, Lysoveta, Revervia, PL+, and the consumer brand Kori Krill, alongside spin-offs AION, focused on reducing and recycling plastic waste, and Understory, a protein brand, and it is listed on the Oslo Stock Exchange under the ticker AKBM.
Average Trading Volume: 27,609
Current Market Cap: NOK8.08B
See more insights into 1PG stock on TipRanks’ Stock Analysis page.